|
1) Vogeser M, Parhofer KG, et al. Liquid chro-matography tandem-mass spectrometry (LC-MS/MS) technique and applications in endocrinology. Exp Clin Endocrinol Diabetes. 2007; 115: 559-70
|
|
|
|
2) Newell-Price J, Bertagna X, Grossman AB, et al. Cushing's syndrome. Lancet. 2006; 367: 1605-17
|
|
|
|
|
|
3) Caetano MS, Silva Rdo C, Kater CE. Increased diagnostic probability of subclinical Cushing's syndrome in a population sample of overweight adult patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metabol. 2007; 51: 1118-27
|
|
|
|
|
|
4) Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008; 93: 1526-40
|
|
|
|
|
|
5) Odagiri E, Naruse M, Terasaki K, et al. The diagnostic standard of preclinical Cushing's syndrome: evaluation of the dexamethasone suppression test using various cortisol kits. Endocr J. 2004; 51: 295-302
|
|
|
|
|
6) 小田桐恵美, 成瀬光栄, 田辺晶代, 他. コルチゾール測定とその問題点 プレクリニカルCushing症候群の診断基準をめぐる問題点. 臨床病理. 2007; 55: 549
|
|
|
|
|
|
7) Katabami T, Obi R, Shirai N, et al. Discrepancies in results of low-and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome. Endocr J. 2005; 52: 463-9
|
|
|
|
|
|
8) 方波見卓行, 小尾竜正, 田中 逸. 副腎性サブ(プレ)クリニカルCushing症候群の診断基準 見直しに向けての課題. 日内分泌会誌. 2008; 84: 159
|
|
|
|
|
|
9) Taylor RL, Machacek D, Singh RJ. Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem. 2002; 48: 1511-9
|
|
|
|
|
|
10) Quinkler M, Stewart PM. Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab. 2003; 88: 2384-92
|
|
|
|
|
|
11) Tomlinson JW, Draper N, Mackie J, et al. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion. J Clin Endocrinol Metab. 2002; 87: 57-62
|
|
|
|
|
|
12) Vogeser M, Groetzner J, Kupper C, et al. The serum cortisol: cortisone ratio in the postopera-tive acute-phase response. Horm Res. 2003; 59: 293-6
|
|
|
|
|
|
13) Taylor RL, Grebe SK, Singh RJ. Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clin Chem. 2004; 50: 2345-52
|
|
|
|
|
|
14) Carroll T, Raff H, Findling JW. Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome. Nat Clin Pract Endocrinol Metab. 2008; 4: 344-50
|
|
|
|
|
|
15) 本間誠次郎, 坂口菊恵. 唾液中ステロイドホルモン測定とその有用性. In: Annual Review 糖尿病・代謝・内分泌 2008. 東京: 中外医学社; 2008. p. 144-54
|
|
|
|
|
|
16) Trilck M, Flitsch J, Ludecke DK, et al. Salivary cortisol measurement--a reliable method for the diagnosis of Cushing's syndrome. Exp Clin Endocrinol Diabetes. 2005; 113: 225-30
|
|
|
|
|
|
17) Doi M, Sekizawa N, Tani Y, et al. Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan. Endocr J. 2008; 55: 121-6
|
|
|
|
|
|
18) Baid SK, Sinaii N, Wade M, et al. Radio-immunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hyper-cortisolism. J Clin Endocrinol Metab. 2007; 92: 3102-7
|
|
|
|
|
|
19) Findling JW, Raff H. Cushing's syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab. 2006; 91: 3746-53
|
|
|
|
|
|
20) 方波見卓行, 小尾竜正. サブ(プレ)クリニカルCushing 症候群診断基準の問題点と改善策. In: Annual Review 糖尿病・代謝・内分泌 2006. 東京: 中外医学社; 2006. p. 199-205
|
|
|
|
|
|
21) 二川原健, 須田俊宏. Pre(sub)-clinical Cushing 病の診断基準 preclinical Cushing 症候群との比較を含めて. In: Annual Review 糖尿病・代謝・内分泌2008. 東京: 中外医学社; 2008. p. 155-61
|
|
|
|
|